Clinical trial
Biological Therapies Following Peripheral Stem Cell Transplantation in Treating…
NCT00005993 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00005993 |
|---|---|
| Title | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer |
| Official title | Immunotherapy With Subcutaneous Il-2 and Stem Cell Factor (SCF) for Patients With Lymphoma or Breast Cancer After Autologous Transplantation |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | aldesleukin, filgrastim, recombinant human stem cell factor, peripheral blood stem cell transplantation |
| Start date | May 1, 1999 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Jun 21, 2004 |
| Last update posted | Nov 29, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: